Picture EBD Group World of Partnering Opportunities 650x100px

Persons > All

Find below all kinds of persons.

Total search results: 8775 | Ordered by Person (ascending)
next pagenext page 1 2 3 ... 79 80 81 ... 86 87 88  next pagenext page

order ascendingorder descendingPerson order ascendingorder descendingPosition order ascendingorder descendingOrganisation (Group) order ascendingorder descendingCountry
van Lent, Horst-Dieter (Omnibal 200906 Head Purchasing) Business Manager Omnilab (DE) (Group) Germany
Van Min, Max (Cergentis 202004 Founding Director) Managing Director Solvias (Group) Netherlands
Van Naarden, Jacob (Loxo Oncology 201711 CBO) Chief Business Officer (CBO) Eli Lilly (Group) United States (USA)
van Pelt, Eva (Eppendorf 201912– Co-CEO joined 201710 before Leica Microsystems + Hitachi + Siemens) Chief Executive Officer (CEO) Eppendorf (Group) Germany
van Renterghem, Guillaume (LifeSci 202106 Managing Director at LifeSci Advisors in Zurich) Public Relations Manager / Investor Relations Manager LifeSci (Group) United States (USA)
Van Rie, Jeroen (Bayer 201706 Crop Efficiency Trait Research expert) n. a. Bayer (Group) Germany
van Tilburg, Maurice (Euronext 201511 CEO of Euronext Amsterdam) Chief Executive Officer (CEO) Euronext (Group) Netherlands
van Tulder, Arnoud (Cryo-Save 201105 CEO) Chief Executive Officer (CEO) Esperite (Group) Netherlands
van Tunen, Arjen (Keygene 200601 CEO) Chief Executive Officer (CEO) KeyGene N.V. Netherlands
Van Vlasselaer, Peter (Avidia 200609 CEO) Chief Executive Officer (CEO) Avigen Inc. (Nasdaq: AVGN) United States (USA)
van Wieringen, Bas (PeelPioneeres 202010) n. a. PeelPioneers B.V. Netherlands
van Winsen, Joris (Labfolder 2015– Managing Director CFO) Managing Director Labforward (Group) Germany
van Zyl, Charl (UCB 202101 EVP Head Neurology Solutions + Intl Markets formerly Jado Technologies + Novartis + Lilly) President/Director/Head Business Group/Unit/Division UCB (Group) Belgium
Vanacker, Peter (Neste 202012 CEO) Chief Executive Officer (CEO) Neste Oyj Finland
Vandenhirtz, Dirk (LemnaTec 201104 Managing Director) Managing Director Nynomic (Group) Germany
Vanderhaegen, Frederic (Tecan 201202 Head Life Sciences Business) President/Director/Head Business Group/Unit/Division Tecan (Group) Switzerland
Vangeel, Frankie (VWR 201602 Managing Director at VWR International GmbH) Managing Director Avantor (Group) Germany
Vanhoyland, Geert (Bruker 201606 Global Product Manager Materials Research at Bruker AXS) Product Manager (personnel) Bruker (Group) Germany
Vann, Christopher (Autolus 201707– COO before Roche) Chief Operating Officer (COO) Autolus Therapeutics plc (Nasdaq: AUTL) United Kingdom (GB)
VanOort, Douglas (NeoGenomics 201703 CEO) n. a. NeoGenomics (Group) United States (USA)
Varma, Suneet (Pfizer 201712 Global President of Pfizer APAC, Greater China + Global Brands) President/Director/Head Business Group/Unit/Division Pfizer (Group) United States (USA)
Varney, Michael D. (Roche 201501–202007 promoted Head of gRED before Genentech RETIRED 7/20) President/Director/Head Business Group/Unit/Division Roche (Group) United States (USA)
Vasella, Daniel (Novartis CEO 199612–201001 after 1/10 continues as Chairman) Board member, non-executive Numab (Group) Switzerland
Vat-Ho, Vatnak (Ryvu Therapeutics 202104– US-based CBO before Affimed Inc + Pfizer) Chief Business Officer (CBO) Ryvu Therapeutics S.A. (WSE: RVU) Poland
Vater, Wulf (Bayer 199710) n. a. Bayer (Group) Germany
Vaussy, Hugues (Eurofins 201707 Finance Director) Chief Financial Officer (CFO) Eurofins (Group) Luxembourg
Vazirani, Suresh (Erba Diagnostics Mannheim 201509 Managing Director) Managing Director Erba Diagnostics Mannheim (Group) Germany
Végh, Mátyás (Creoptix 201210–201912 Managing Partner before Genetics Company LEFT 1/20) Managing Partner Spectris (Group) Switzerland
Veidman, Avi (Nucleai MD 202007 CEO + Co-Founder) Chief Executive Officer (CEO) Nucleai MD (IL) Israel
Veinbergs, Isaac (Libra Therapeutics 202009– CEO) Chief Executive Officer (CEO) Libra Therapeutics Inc. United States (USA)
Veitch, David (Basilea 201804– CEO before CCO since 201408 before Savient + BMS) Chief Executive Officer (CEO) Basilea (Group) Switzerland
Veitschegger, Andrea (ÖGMBT 201105 Managing Director) Managing Director Österreichische Gesellschaft für Molekulare Biowissenschaften und Biotechnologie (ÖGMBT) Austria
Velasco, Martin (AC Immune 201401 Board Chairman) Board member, non-executive AC Immune S.A. (Nasdaq: ACIU) Switzerland
Velden, Torsten (Bayer 201208 Bayer CropScience Country Head for Vietnam) Regional manager Bayer (Group) Germany
Veldman, Robert (Bipharma 201204 CEO) Chief Executive Officer (CEO) Bipharma B.V. Netherlands
Velling, Johannes (NRW (govt) 202106 Deputy Head Dept Startups + Digital Impulse at MWIDE before Germany (govt)) Administrative Officer (personnel) Nordrhein-Westfalen (govt region) Germany
Velten, Jürgen n. a. Baden-Württemberg (govt region) Germany
Venkayya, Rajeev (Aerium Therapeutics 202203– CEO before Takeda 201510 President of Vaccine Business Unit) Chief Executive Officer (CEO) Aerium Therapeutics Inc. United States (USA)
Venter, J. Craig n. a. VENTER Group [Craig Venter / Claire Fraser] (Group) United States (USA)
Ventur, Yvonne (Orexo 201207 Kibion Country Manager Germany) Regional manager Mayoly Spindler (Group) Germany
Venturi, Miro (Novigenix 202211 Board Director) Board member (all kinds of boards: supervisory, advisory, management etc.) Novigenix S.A. Switzerland
Veraart, Manon (Quercis Pharma 202104– CBO before Compass Pathways + Boston Consulting + Goldman Sachs) Chief Executive Officer (CEO) Quercis Pharma (Group) Switzerland
Veraitch, Farlan (Ori Biotech 202005 CSO + Co-Founder) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Ori Biotech (Oribiotech) (Group) United Kingdom (GB)
Verbraeken, Paul (Evolva 201105 Investor Relations Manager) Public Relations Manager / Investor Relations Manager Evolva (Group) Switzerland
Verghese, Jacob (Trophic Communications 201811) Public Relations Manager / Investor Relations Manager Trophic Communications GmbH Germany
Verhaeghe, Peter (Benaruca 200910) Investment Manager Benaruca (LU) (family offfice of Rudi Pauwels) Luxembourg
Verhaert, Raymond (ProteoNic 201105 CSO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) ProteoNic Biotechnology B.V. Netherlands
Verhey, Janko F. (MVIP ImagingProducts 200912 Managing Director + Co-Founder) Managing Director MVIP (Group) Germany
Verhey, Martina (MVIP ImagingProducts 200912 Managing Director + Co-Founder) Managing Director MVIP (Group) Germany
Verheyen, Frank (Techniker Krankenkasse 200901– Director of WINEG) President/Director/Head Business Group/Unit/Division Techniker Krankenkasse (Group) Germany
Verhoef, Clarence (Varex Imaging 201701– CFO) Chief Financial Officer (CFO) Varex Imaging (Group) United States (USA)
Verhoeven, Wouter (BioGeneration Ventures 202109– Venture Partner before NBE-Therapeutics + mAbxience) Partner (venture partner) BioGeneration Ventures B.V. (BGV) Netherlands
Verjee, Rehan (Precede Biosciences 202310 CEO + Co-Founder before EMD Serono) Chief Executive Officer (CEO) Precede Biosciences (US) United States (USA)
Verkamman, Annemiek (HollandBIO 201912 Managing Director) Managing Director HollandBIO Netherlands
Verland, Sten (Sunstone Capital 200705– Partner Life Science Ventures) Partner (venture partner) Sunstone Life Science (Group) Denmark
Verlenden, Darren (Merck (DE) 2022 Head of Proccess Solutions at Life Science Business Sector) President/Director/Head Business Group/Unit/Division Merck (DE) (Group) Germany
Vermeylen, Krisja (Novo Group 201704 SPV Corp People + Organisation joined before 1997 before Pharmacia) President/Director/Head Business Group/Unit/Division Novo Group (Group) Denmark
Veromaa, Timo (BioTie 1998– VP RnD promoted CEO 5/05 before Schering Oy before Collagen Corp) Chief Executive Officer (CEO) Acorda Therapeutics (Group) Finland
Verrelst, Herman (Biocartis 202304– Board Chair before CEO before Agilent + Cartagenia + Medicim + Data4s) Board member, non-executive Biocartis (Group) Belgium
Vertes, Akos (George Washington Univ 2000– Prof before Associate Prof since 1991) Professor George Washington University United States (USA)
Ververken, Cedric (Confo Therapeutics 201610– CEO before Ablynx) Chief Executive Officer (CEO) Confo Therapeutics N.V. Belgium
Verwiel, Frank (ObsEva 2016– Board Director before CEO of Aptalis Pharma) n. a. ObsEva (Group) Switzerland
Verzetnitsch, Ulrike (Apceth 201612 CTO at Apceth Biopharma GmbH) Chief Technology/Technical Officer (CTO) Resonac (Group) Germany
Vessey, Rupert (Celgene 201701 EVP + President RnD before Merck & Co 200906 VP Merck Research Laboratories) President/Director/Head Business Group/Unit/Division Bristol Myers Squibb (BMS) (Group) United States (USA)
Vetter, Dirk (Perora GmbH 201306– Managing Director + Co-founder) Managing Director Perora GmbH Germany
Vetter, Nicholas (UV-Cap 202011) n. a. UV-Cap (Vetter family office) (Group) Germany
Vetter, Udo J. (UV-Cap 201702 Founder + Managing Director) Managing Director
Veugelers, Mark (VIB 201408 Tech Watch team) IP Manager VIB (Flanders Interuniversity Institute for Biotechnology / Vlaams Instituut voor Biotechnologie) Belgium
Vianna, Eduardo (NovaGo Therapeutics 202009– Chief Development Officer before CEO) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) NovaGo Therapeutics AG Switzerland
Vicari, Alain (Calypso Biotech 201703 CEO) Chief Executive Officer (CEO) Calypso Biotech (Group) Switzerland
Viehbacher, Christopher A. (Chris) (Biogen 202307 CEO before Gurnet Point Capital + Sanofi + GSK) Managing Partner BERTARELLI Group (family of Ernesto Bertarelli) United Kingdom (GB)
Vieira, Samantha (Anjarium Biosciences 202207– COO before Biogen + Nightstar Therapeutics) Chief Operating Officer (COO) Anjarium Biosciences AG Switzerland
Vielsack, Claus (Stratec 201402– Executive Management Board Member for Product Development joined 1998) Board member, executive Stratec (Group) Germany
Viëtor, Henk (Oncodrone 201508 CEO before Skyline Diagnostics CEO) Chief Executive Officer (CEO) SkylineDx B.V. Netherlands
Vigneault, Francois (AbVitro 201410 CSO + Co-founder) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) Bristol Myers Squibb (BMS) (Group) United States (USA)
Vignon, Guillaume (BeiGene 201810 SVP Business Development at BeiGene Switzerland GmbH) Business Development Manager / Strategy Manager BeiGene (Group) Switzerland
Vignot, Julien (Vifor Pharma 202111 Head of Investor Relations) Public Relations Manager / Investor Relations Manager Vifor Pharma (Group) Switzerland
Vile, Hollie (Optimum Strategic Communicatons 201710 before Hume Brophy + M:Communications) Public Relations Manager / Investor Relations Manager Optimum Strategic Communications United Kingdom (GB)
Villain-Guillot, Philippe (Nosopharm 201703 President) Chief Executive Officer (CEO) Nosopharm S.A.S. France
Villinger, Thomas R. (Tom) (ZFHN Zukunftsfonds Heilbronn 201910 CEO) Chief Executive Officer (CEO) Zukunftsfonds Heilbronn (Group) Germany
Vincent, Kathy (Greig Communications 202301) Public Relations Manager / Investor Relations Manager Greig Communications Inc. United States (USA)
Vink, Patrick (Forbion 202007c– Operating Partner former COO of Cubist before Mylan + Sandoz) Partner (venture partner) Forbion (Group) Netherlands
Viragh, Eszter (BMS 202203 Head of Corporate Affairs at BMS Germany) Public Relations Manager / Investor Relations Manager Bristol Myers Squibb (BMS) (Group) Germany
Virani, Shafique (Recursion 202009 Chief Corp Development Officer formerly Roche Global Head Neuroscience Partnering) Business Development Manager / Strategy Manager Recursion Pharmaceuticals (Group) United States (USA)
Virchow, Sebastian n. a. Deutsche Bank (Group) Germany
Viribay, Miguel-Antonio (Sygnis 201504– VP Sales + Marketing before Thermo Fisher + Agilent + Life Technologies) Sales Manager / Marketing Manager 2invest (Group) Germany
Virji, Sukaina (Suki) (Consilium 201706– joins London CSC office before 16y at Scrip/Informa) Public Relations Manager / Investor Relations Manager ICR (Group) United Kingdom (GB)
Viswanadhan, Krishnan (Be Biopharma 202208– COO + President before BMS + Celgene + Advyzom + Roche) Chief Operating Officer (COO) Be Biopharma Inc. United States (USA)
Vita, Giuseppe (Schering) n. a. Bayer (Group) Germany
Vitt, Daniel (Immunic 201701– CEO before 4SC 1997–201612 CSO + Co-Founder before Univ Würzburg) Chief Executive Officer (CEO) Immunic (Group) Germany
Vlachou, Angelika (High-Tech Gründerfonds 202110 VC Professional formerly bmp 201702 Investment Manager bmp) Investment Manager High-Tech Gründerfonds (HTGF) (Group) Germany
Vlasak, Reinhard (Angewandte Biotechnologie GmbH 200810 CEO) Chief Executive Officer (CEO) Angewandte Biotechnologie GmbH (Applied BioTech – ABT) Austria
Vodopivec, Alexander (ViruSure 201211 Managing Director, Finance + Administration) Managing Director ViruSure GmbH Austria
Voegeli, Rainer (BioVisioN 200412 CBO) Chief Business Officer (CBO) Digilab (Group) Germany
Vogel, Bernard (Endeavour Vision 201409 Managing Partner + Co-founder) Managing Partner (investment firm) Endeavour Vision (Group) Switzerland
Vogel, Florian (MYR Pharmaceuticals 202006 CCO) Chief Commercial Officer (CCO) Gilead Sciences (Group) Germany
Vogel, Hanspeter (Bruker 201009 Director RI Research Instruments GmbH) n. a. Bruker (Group) Germany
Vogelmeier, Claus (Univ Gießen 201503 Professor of Internal + Respiratory Medicine) Professor University of Gießen (Justus Liebig University) Germany
Vogelstein, Bert (Johns Hopkins Univ 201704 Professor) Professor Johns Hopkins University United States (USA)
Vogeser, Gudrun (PIKA Weihenstephan GmbH 201308 Managing Director + Co-founder) Managing Director PIKA Weihenstephan GmbH Germany
next pagenext page 1 2 3 ... 79 80 81 ... 86 87 88  next pagenext page


Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Berlin Partner Join Cluster HealthCapital Berlin Brandenburg 650x300px

» top